Literature DB >> 17510535

Spontaneous regression of diffuse large B-cell lymphoma harbouring Epstein-Barr virus: a case report and review of the literature.

Rokuo Abe1, Kazuei Ogawa, Yukio Maruyama, Naoya Nakamura, Masafumi Abe.   

Abstract

We report an elderly patient with diffuse large B cell lymphoma harbouring Epstein-Barr virus that showed spontaneous regressions with subsequent relapses three times. The patient died of aspiration pneumonia without any anti-neoplastic treatment 5 years 10 months after the initial onset of lymph node swelling. In the literature, there are several reports of aggressive non-Hodgkin's lymphoma cases that showed spontaneous regressions without relapse till the last observation. Over half of the cases were the extra-nodal type. The tendency toward regression of swollen lymph nodes detected by clinicians occurs within 2 weeks after biopsy. If the remaining lymph nodes show a tendency to decrease in size after biopsy without any anti-tumor therapies, the patient may develop spontaneous regression.

Entities:  

Mesh:

Year:  2007        PMID: 17510535     DOI: 10.3960/jslrt.47.23

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  19 in total

1.  Spontaneous remission in localized diffuse large B-cell lymphoma.

Authors:  László Tamás; Eszter Sári; Gábor Répássy; Péter Szabó; Eniko Bagdi; László Krenács; Judit Demeter
Journal:  Pathol Oncol Res       Date:  2011-06-10       Impact factor: 3.201

2.  Modelling lymphoma therapy and outcome.

Authors:  Katja Roesch; Dirk Hasenclever; Markus Scholz
Journal:  Bull Math Biol       Date:  2013-12-14       Impact factor: 1.758

3.  Sudden appearance and spontaneous regression of diffuse large B cell lymphoma in a man with a broken arm.

Authors:  Peter A Engel; Ching Lee
Journal:  BMJ Case Rep       Date:  2009-03-05

4.  A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma.

Authors:  D Ito; M M Endicott; C M Jubala; K M Helm; R C Burnett; B D Husbands; A Borgatti; M S Henson; K E Burgess; J S Bell; W C Kisseberth; V E Valli; G R Cutter; A C Avery; K A Hahn; T D O'Brien; J F Modiano
Journal:  J Vet Intern Med       Date:  2011 Jul-Aug       Impact factor: 3.333

5.  Spontaneous Regression of Diffuse Large B-cell Lymphoma in a Patient with Ataxia-Telangiectasia.

Authors:  Roya Sherkat; Noushin Afshar Moghaddam; Nahid Reisi; Marzieh Rezaei
Journal:  Adv Biomed Res       Date:  2022-04-29

6.  Primary diffuse large B-cell lymphoma of the CNS: a rare case of spontaneous remission.

Authors:  Fotini Debonera; Sunita Nasta; Maria Martinez-Lage; Stephen J Schuster; Donald E Tsai
Journal:  Int J Hematol Oncol       Date:  2017-11-20

7.  Diffuse large B-cell lymphoma with a high number of epithelioid histiocytes (lymphoepithelioid B-cell lymphoma): a study of Osaka Lymphoma Study Group.

Authors:  Naoki Wada; Junichiro Ikeda; Masaharu Kohara; Hiroyasu Ogawa; Masayuki Hino; Shirou Fukuhara; Akihisa Kanamaru; Haruo Sugiyama; Yuzuru Kanakura; Eiichi Morii; Katsuyuki Aozasa
Journal:  Virchows Arch       Date:  2009-09       Impact factor: 4.064

8.  Clear cell variant of diffuse large B-cell lymphoma: a case report.

Authors:  Suzana Manxhuka-Kerliu; Gordana Petrusevska; Irma Kerliu; Emrush Kryeziu; Fehmi Ahmeti; Emine Devolli-Disha; Vjollca Sahatciu-Meka; Sadushe Loxha; Labinot Shahini
Journal:  J Med Case Rep       Date:  2011-05-13

9.  Age-related Epstein-Barr virus-positive cutaneous ulcer arising after a self-limited subcutaneous abscess: a case report.

Authors:  Shemsedin Sadiku; Fisnik Kurshumliu; Xhevdet Krasniqi; Ahmet Brovina; Emrush Kryeziu; Ibrahim Rrudhani; Kastriot Meqa; Lumturije Gashi-Luci; Hartmut Merz
Journal:  J Med Case Rep       Date:  2012-09-11

10.  Spontaneous regression of plasmablastic lymphoma in an elderly human immunodeficiency virus (HIV)-negative patient.

Authors:  Takuro Igawa; Yasuharu Sato; Hotaka Kawai; Eisei Kondo; Mai Takeuchi; Tomoko Miyata-Takata; Katsuyoshi Takata; Tadashi Yoshino
Journal:  Diagn Pathol       Date:  2015-10-06       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.